2,6-Bis((4S,5S)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine

Catalog No. :
ACJIDM831
CAS No. :
1221973-02-9
Molecular Formula :
C35H29N5
Molecular Weight :
519.65

IUPAC Name:2,6-bis((4S,5S)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine

2,6-Bis((4S,5S)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$92.00Login to see priceIn stockInquiry
1g97%$367.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Bis((4S,5S)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine
IUPAC Name2,6-bis((4S,5S)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine
MDL No.MFCD32639207
Molecular FormulaC35H29N5
Molecular Weight519.65
SMILESC1(C2=N[C@@H](C3=CC=CC=C3)[C@H](C4=CC=CC=C4)N2)=NC(C5=N[C@@H](C6=CC=CC=C6)[C@H](C7=CC=CC=C7)N5)=CC=C1
InChI KeyAPPVMXCHSLHBIP-YRCZKMHPSA-N
Synonym2,6-bis[(4S,5S)-4,5-dihydro-4,5-diphenyl-1H-imidazol-2-yl]-Pyridine;Pyridine, 2,6-bis[(4S,5S)-4,5-dihydro-4,5-diphenyl-1H-imidazol-2-yl]-;2,6-Bis((4S,5S)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine
CAS No.1221973-02-9
PubChem CID139291767

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJIDM831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJIDM831 route product structure diagram
    ACJIDM8311221973-02-9 In Stock
Inquiry

2. ACJIDM831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJIDM831 route product structure diagram
    ACJIDM8311221973-02-9 In Stock
Inquiry

Comments (0)